Cargando…

Cost-Utility Analysis of Planned Early Delivery or Expectant Management for Late Preterm Pre-eclampsia (PHOENIX)

AIM: There is currently limited evidence on the costs associated with late preterm pre-eclampsia beyond antenatal care and post-natal discharge from hospital. The aim of this analysis is to evaluate the 24-month cost-utility of planned delivery for women with late preterm pre-eclampsia at 34(+0)–36(...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hunter, Rachael, Beardmore-Gray, Alice, Greenland, Melanie, Linsell, Louise, Juszczak, Edmund, Hardy, Pollyanna, Placzek, Anna, Shennan, Andrew, Marlow, Neil, Chappell, Lucy C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440173/ https://www.ncbi.nlm.nih.gov/pubmed/35861912 http://dx.doi.org/10.1007/s41669-022-00355-1

Ejemplares similares

Two‐year follow‐up of infant and maternal outcomes after planned early delivery or expectant management for late preterm pre‐eclampsia (PHOENIX): A randomised controlled trial
por: Beardmore‐Gray, Alice, et al.
Publicado: (2022)

Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial
por: Chappell, Lucy C, et al.
Publicado: (2019)

Planned delivery or expectant management for late preterm pre-eclampsia: study protocol for a randomised controlled trial (PHOENIX trial)
por: Chappell, Lucy C., et al.
Publicado: (2019)

Planned early delivery for late preterm pre-eclampsia in a low- and middle-income setting: a feasibility study
por: Beardmore-Gray, Alice, et al.
Publicado: (2021)

Baby-OSCAR: Outcome after Selective early treatment for Closure of patent ductus ARteriosus in preterm babies—a statistical analysis plan for short-term outcomes
por: Bell, Jennifer L., et al.
Publicado: (2021)

Correction to: Baby-OSCAR: Outcome after Selective early treatment for Closure of patent ductus ARteriosus in preterm babies—a statistical analysis plan for short-term outcomes
por: Bell, Jennifer L., et al.
Publicado: (2021)

Planned early delivery versus expectant management to reduce adverse pregnancy outcomes in pre-eclampsia in a low- and middle-income setting: study protocol for a randomised controlled trial (CRADLE-4 Trial)
por: Beardmore-Gray, Alice, et al.
Publicado: (2020)

E-Freeze - a randomised controlled trial evaluating the clinical and cost effectiveness of a policy of freezing embryos followed by thawed frozen embryo transfer compared with a policy of fresh embryo transfer, in women undergoing in vitro fertilisation: a statistical analysis plan
por: Bell, Jennifer L., et al.
Publicado: (2020)

Placental Growth Factor (PlGF) in Women with Suspected Pre-Eclampsia Prior to 35 Weeks’ Gestation: A Budget Impact Analysis
por: Duckworth, Suzy, et al.
Publicado: (2016)

Ursodeoxycholic acid versus placebo in the treatment of women with intrahepatic cholestasis of pregnancy (ICP) to improve perinatal outcomes: protocol for a randomised controlled trial (PITCHES)
por: Chappell, Lucy C., et al.
Publicado: (2018)

Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial
por: Duhig, Kate E, et al.
Publicado: (2019)

Comparison of three commercially available placental growth factor‐based tests in women with suspected preterm pre‐eclampsia: the COMPARE study
por: McCarthy, F. P., et al.
Publicado: (2018)

Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial
por: Chappell, Lucy C, et al.
Publicado: (2019)

The Microbiome of Infants Recruited to a Randomised Placebo-controlled Probiotic Trial (PiPS Trial)
por: Millar, Michael, et al.
Publicado: (2017)

Study protocol: baby-OSCAR trial: Outcome after Selective early treatment for Closure of patent ductus ARteriosus in preterm babies, a multicentre, masked, randomised placebo-controlled parallel group trial
por: Gupta, Samir, et al.
Publicado: (2021)

Correction to: Study protocol: baby-OSCAR Trial: Outcome after Selective early treatment for Closure of patent ductus ARteriosus in preterm babies, a multicentre, masked, randomised placebo-controlled parallel group trial
por: Gupta, Samir, et al.
Publicado: (2021)

Placental growth fActor Repeat sampling for Reduction of adverse perinatal Outcomes in women with suspecTed pre-eclampsia: study protocol for a randomised controlled trial (PARROT-2)
por: Hurrell, Alice, et al.
Publicado: (2022)

Placental growth factor testing for suspected pre‐eclampsia: a cost‐effectiveness analysis
por: Duhig, KE, et al.
Publicado: (2019)

Designing the CORONIS trial. Why a non-regular fractional factorial design?
por: Hardy, Pollyanna, et al.
Publicado: (2013)

Association of Proteinuria Threshold in Pre-Eclampsia with Maternal and Perinatal Outcomes: A Nested Case Control Cohort of High Risk Women
por: Bramham, Kate, et al.
Publicado: (2013)

Recent advances in the diagnosis and management of pre-eclampsia
por: Duhig, Kate E., et al.
Publicado: (2015)

Recent advances in the diagnosis and management of pre-eclampsia
por: Duhig, Kate, et al.
Publicado: (2018)

Multicenter Cohort Study, With a Nested Randomized Comparison, to Examine the Cardiovascular Impact of Preterm Preeclampsia
por: McCarthy, Fergus P., et al.
Publicado: (2021)

Incidence of eclampsia and related complications across 10 low- and middle-resource geographical regions: Secondary analysis of a cluster randomised controlled trial
por: Vousden, Nicola, et al.
Publicado: (2019)

CORRIGENDUM TO: Recent advances in the diagnosis and management of pre-eclampsia
por: Duhig, Kate E., et al.
Publicado: (2015)

Phoenix
por: Cvetaeva, Marina
Publicado: (2001)

Recent advances in the diagnosis and management of pre-eclampsia
por: Hurrell, Alice, et al.
Publicado: (2020)

Early warning system hypertension thresholds to predict adverse outcomes in pre-eclampsia: A prospective cohort study
por: Nathan, Hannah L., et al.
Publicado: (2018)

Late Onset Postpartum Eclampsia: It is Really Never Too Late—A Case of Eclampsia 8 Weeks after Delivery
por: Minnerup, Jens, et al.
Publicado: (2009)

PREPARE: protocol for a stepped wedge trial to evaluate whether a risk stratification model can reduce preterm deliveries among women with suspected or confirmed preterm pre-eclampsia
por: Dias, Marcos Augusto Bastos, et al.
Publicado: (2019)

Application of the matched nested case-control design to the secondary analysis of trial data
por: Partlett, Christopher, et al.
Publicado: (2020)

Phoenix in Action
por: Lessel, Geoffrey
Publicado: (2019)

Who is Phoenix?
por: D'Angelo, Roberto
Publicado: (2020)

An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc): study protocol for a randomised controlled trial
por: Hill, Louise F., et al.
Publicado: (2020)

Maternal and perinatal adverse outcomes in women with pre-eclampsia cared for at facility-level in South Africa: a prospective cohort study
por: Nathan, Hannah L, et al.
Publicado: (2018)

Late‐stage Cesarean section causes recurrent early preterm birth: how to tackle this problem?
por: Glazewska‐Hallin, A., et al.
Publicado: (2019)

Mass Spectrometry-Based Proteomics for Pre-Eclampsia and Preterm Birth
por: Law, Kai P., et al.
Publicado: (2015)

Does Preeclampsia Predict the Risk of Late Postpartum Eclampsia?
por: Wolfe, Diana S., et al.
Publicado: (2013)

Real-Time Phoenix
por: Bussey, Stephen
Publicado: (2020)

The Cluster and Phoenix missions
por: Escoubet, C, et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_4gi9bjas6c5qrn0hakj4h4jlro